Showing 5181-5190 of 19420 results for "".
National Healthcare Scorecard: the Economy
https://reachmd.com/programs/clinicians-roundtable/national-healthcare-scorecard-the-economy/152/Michael Zamore, a policy advisor for Rep. Patrick Kennedy of Rhode Island explains how the heathcare system impacts the economy of the U.S.Ethics of Living Donor Transplantation
https://reachmd.com/programs/clinicians-roundtable/ethics-of-living-donor-transplantation/82/Dr. Simmerling describes the ethical issues of consent and autonomy for living transplant donors, and how these considerations compare between related versus unrelated donors.Patient Empowerment and Rapid Response
https://reachmd.com/programs/clinicians-roundtable/patient-empowerment-and-rapid-response/42/Ms. Merryman discusses the changes in her hospital setting invoking increased patient empowerment and the evolution of the rapid response system.Diagnosing and Treating Benign Prostatic Hyperplasia and Overactive Bladder
https://reachmd.com/programs/clinicians-roundtable/diagnosing-and-treating-benign-prostatic-hyperplasia-and-overactive-bladder/33039/Advancements in diagnostics and treatment have led to enhanced personalized care for patients with benign prostatic hyperplasia (BPH) and overactive bladder (OAB). Minimally invasive treatments have the potential to replace medication for BPH, while a greater focus on bladder health can help differeAligning Patient and Physician Perspectives in Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/aligning-patient-and-physician-perspectives-in-psoriatic-arthritis/56879/Balancing patient and physician-reported outcomes in psoriatic arthritis is essential, especially because perceptions of disease control often differ. In this episode, Dr. Laura Coates discusses how addressing this disconnect can improve communication, guide holistic care, and enhance patient outcomThe Evolving gMG Treatment Landscape
https://reachmd.com/programs/neurofrontiers/the-evolving-gmg-treatment-landscape/30070/The newest findings on generalized myasthenia gravis treatment include FcRn inhibitors and B-cell targeting. Catch up now.Doctor as Patient Advocate: Top Tools to Empower Your Patients
https://reachmd.com/programs/heart-matters/doctor-as-patient-advocate-top-tools-to-empower-your-patients/5591/Recommendations and ratings are a dime a dozen for patients looking for more information about a physician or procedure online, but finding quality, consumer-friendly information that's also reliable can be more of a challenge. What tools can physicians recommend to patients for understanding the imRecognizing the Full Spectrum of MS Symptoms: Multidisciplinary Pathways to Better Care
https://reachmd.com/programs/neurofrontiers/program-name/36355/Multiple sclerosis (MS) presents a diverse range of symptoms that require coordinated, expert care. Dr. Marisa McGinley, a neurologist at the Cleveland Clinic, provides practical strategies for neurologists to serve as the central point of contact for patients with MS, initiate targeted treatments,Measuring What Matters in Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/measuring-what-matters-in-psoriatic-arthritis/56349/Measuring outcomes in psoriatic arthritis is complex, because the disease affects multiple domains and varies widely between patients. As a result, capturing both clinical disease activity and the real-world impact on patients’ quality of life is essential for guiding care. Tune in to hear Dr. LauraNavigating the Vascular Risks of Cancer Therapy: Balancing Cardiac Safety and Tumor Control
https://reachmd.com/programs/heart-matters/navigating-the-vascular-risks-of-cancer-therapy-balancing-cardiac-safety-and-tumor-control/37203/Cancer therapies can trigger both acute and chronic vascular effects, from treatment-induced hypertension to long-term atherosclerotic changes. Learn more as Dr. Jun-ichi Abe shares insights from his presentation at the 2025 American Heart Association Scientific Sessions. Dr. Abe is a Professor in t